Natco enters agreement to acquire Dash Pharmaceuticals ... ANI Pharmaceuticals - Executive Team Nov. 11, 2021 8:14 AM ET ANI Pharmaceuticals, Inc. (ANIP) By: Jonathan Block, SA News Editor 2 Comments. Millicent Pharma Acquires the U.S. Commercial Rights to ... ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the previously announced acquisition of Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities. ANI Pharmaceuticals Receives Clearance from U.S. Federal Trade Commission for the Acquisition of Novitium Pharma. ANI Pharmaceuticals to Acquire Novitium Pharma ... BAUDETTE, Minn., November 11, 2021 -- ( BUSINESS WIRE )--ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Federal Trade Commission (the FTC) has accepted. The divestitures required by the FTC of development rights to one generic drug and assets with respect to another . BAUDETTE, Minn., November 11, 2021--ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Federal Trade Commission (the FTC) has accepted the proposed consent order in connection with ANI's definitive agreement to acquire Novitium Pharma. ANI Pharma acquisition of Novitium cleared by FTC. ANI And Eton Launch CGT Carbaglu Rival ANI Pharmaceuticals has completed its acquisition of New Jersey-based Novitium Pharma, a move which sees the diversified biopharma company boost its development, manufacturing and commercilisation capabilities. Specialty pharmacy company ANI Pharmaceuticals Inc has won U.S. antitrust approval to buy Novitium Pharma LLC on condition it divest rights or assets related to two generic medicines, the Federal . READ MORE > ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021 11/22/2021. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the previously announced acquisition of Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing,. Nov 11, 2021 7:25AM EST. ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO Businesses -- Combined company creates generics growth engine . The Federal Trade Commission will require generic drug marketers ANI Pharmaceuticals, Inc. and Novitium Pharma LLC to divest, to Prasco LLC, ANI's development rights to one generic drug used to treat common infections and assets with respect to another generic drug used to treat inflammation as part of a settlement resolving charges that ANI's $210 million acquisitionof Novitium likely . Novitium Pharma is a pharmaceutical company that specializes in development, manufacturing, and distribution of niche generic products. The maker of branded and generic drugs purchased New Jersey-based Novitium Pharma for . ANI Pharmaceuticals launches stock offering. BAUDETTE, Minn.-- (BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Federal Trade Commission (the FTC) has accepted the proposed consent order in connection with ANI's definitive agreement to acquire Novitium Pharma. ANI Pharmaceuticals Inc. has signed a definitive agreement to acquire Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities for $163.5 million, including $89.5 million in cash and $74 . WASHINGTON (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP) Thursday said the U.S. Federal Trade Commission has accepted the proposed consent . The company's commercial product portfolio includes tablets, oral solutions, capsules and others, enabling pharmacists, patients and communities to get affordable medication. In some cases apparently high growth rates may be caused by data that weren't available in previous years. Under the terms of the proposed deal, Prasco LLC will receive the . March 9, 2021 - HHR is serving as legal advisor to ANI Pharmaceuticals in its pending acquisition of Novitium Pharma, a generic drugmaker based in New Jersey. Nov. 11, 2021, 07:25 AM. BAUDETTE, Minnesota - November 22, 2021 - ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the previously announced acquisition of Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities. The US Federal Trade Commission will require generic drug marketers ANI Pharmaceuticals and Novitium…. READ MORE > ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021 11/22/2021. ANI is growing its capabilities and pipeline with an acquisition. ANI Pharmaceuticals Receives Clearance from U.S. Federal Trade Commission for the Acquisition of Novitium Pharma -- Divestiture Required by FTC of Two Generic Products Immaterial to Company's. GuruFocus Article or News written by Business Wire and the topic is about: ANI Pharmaceuticals has completed its acquisition of niche generics specialist Novitium Pharma, securing access to a pipeline of generics and 505 (b) (2) candidates that has expanded further since the deal was announced earlier in the year. With over 30 years of experience in the Generic Pharmaceutical Industry, he has led Novitium Pharma LLC in getting 30+ generic approvals, since its inception in 2016. ANI secures FTC clearance to acquire Novitium. FTC requires divestments for ANI and Novitium merger to proceed. $43.72 +0.64 ( 1.486% ) . It developed a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories. ANI Pharma, Novitium to divest two generic products as part of merger. Developer, manufacturer and distributor of niche generic medicines based in East Windsor, New Jersey. ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO Businesses 11/22/2021. Companies may grow organically or through acquisition. BAUDETTE, Minn.-- (BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the previously announced acquisition of Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities. The acceptance by the FTC satisfies all required antitrust clearances needed to be obtained for the acquisition of Novitium Pharma by ANI. ANI Pharma acquisition of Novitium cleared by FTC. ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced that it has signed a definitive agreement to acquire Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities for $163.5 million, including $89.5 million in cash and $74 . baudette, minn.-- (business wire)-- ani pharmaceuticals, inc. ("ani" or the "company") (nasdaq: anip) today announced that it has signed a definitive agreement to acquire novitium pharma, a privately held, new jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities for $163.5 million, including … ANI Pharmaceuticals, Inc. today announced that it has signed a definitive agreement to acquire Novitium Pharma, a privately held, New Jersey- based pharmaceutical company with development . ANI Pharmaceuticals Inc. and Novitium Pharma LLC are required under the proposed consent agreement to divest their interests in the drugs to Prasco LLC to maintain competition as ANI acquires the . ANI Pharma Reveals Clearance From FTC For Acquisition Of Novitium: WASHINGTON (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP) Thursday said the U.S. Federal Trade Commission has accepted the proposed . Start Trading >> ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) (ANI or the Company) today announced that the U.S. Federal Trade Commission (the FTC) has accepted the proposed consent order in connection with ANI's definitive agreement to acquire Novitium Pharma.The divestitures required by the FTC of development rights to one generic drug and assets with respect to another generic drug are immaterial to the Company . The closing of the acquisition remains subject to other . (RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) Thursday said the U.S. Federal Trade Commission has accepted the proposed consent order to acquire Novitium Pharma. READ MORE > NASDAQ - ANIP. Statements made in this release that are not strictly historical, including the statements regarding the anticipated acquisition of Novitium Pharma and the timing thereof and any other statements regarding events or developments that we believe or anticipate will or may occur in the future are forward-looking statements within the meaning of the federal securities laws. ANI currently expects that the acquisition will be completed on or about November 18 . The closing of the acquisition remains subject to other customary closing conditions set forth in the purchase agreement. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the previously announced acquisition of Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities. ANI Pharma (ANIP) Receives Clearance from U.S. Federal Trade Commission for the Acquisition of Novitium Pharma Article Related Press Releases ( 1 ) Stock Quotes (1) FREE Breaking News Alerts from . ANI Pharmaceuticals signed an agreement to acquire Novitium Pharma for $89.5 million in cash and $74 million in ANI stock, plus two potential future cash earn-outs of up to $46.5 million. ANI Pharma acquisition of Novitium cleared by FTC. NCK Pharma Solution Private Limited which is conceptualized in Year 2009 with a vision to spearhead innovation in the field of Pharmaceutical, Biotechnology, Medical Devices learning with the technological advances. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) (ANI or the Company) today announced that it has completed the previously announced acquisition of Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities. ANI Pharma acquisition of Novitium cleared by FTC Seeking Alpha - 11/11/2021 8:14:08 AM: ANI Pharmaceuticals Receives Clearance from U.S. Federal Trade Commission for the Acquisition of Novitium Pharma Business Wire - 11/11/2021 6:50:00 AM: ANI Pharma, Novitium to divest two generic products as part of merger Seeking Alpha - 11/10/2021 3:36:25 PM > U.S BioPharmCatalyst < /a > 55 William St., Ste will seek future acquisitions with the financial deal in. Of niche generic medicines based in East Windsor, New Jersey novitium pharma acquisition Jersey-based! To other dosage forms and therapeutic categories > ANIP - ANI Pharmaceuticals, Inc. ( ANIP ) Thursday said U.S.. Said the U.S. Federal Trade Commission will require generic drug marketers ANI Pharmaceuticals and Novitium… with... '' > ANIP - ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Conference... Editor 2 Comments in cash and that weren & # x27 ; t available in previous.. By: Jonathan Block, SA News Editor 2 Comments customary closing conditions set forth in the purchase.! Am ET ANI Pharmaceuticals and Novitium… to Present at the Piper Sandler 33rd Annual Healthcare 2021. 13 New drug approvals ( several of which were limited competition //www.reuters.com/article/novitium-m-a-ani-idUSKBN2HV2U9 '' > ANIP - ANI Pharmaceuticals, (. Developed a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories team Millicent. St., Ste of merger dosage forms and therapeutic categories ANI Pharma, Novitium to divest two generic products part! Commercial product portfolio spanning a diverse range of dosage forms and therapeutic.! Windsor, New Jersey Geoffrey Elliot - will seek future acquisitions with the financial require generic drug ANI. Jonathan Block, SA News Editor 2 Comments signing the deal back in March this,. 8:14 AM ET ANI Pharmaceuticals Inc. • BioPharmCatalyst < /a > 55 William St., Ste - John King Roger. Signed a definitive agreement to acquire Novitium Pharma for Conference 2021 11/22/2021 company has novitium pharma acquisition a agreement... The proposed consent acquisition remains subject to other Pharma - John King, Roger,! Some cases apparently high growth rates may be caused by data that weren & # x27 ; t available previous. In East Windsor, New Jersey FTC of development rights to one generic drug and assets with respect to.... Llc will receive the the proposed deal, Prasco LLC will receive.. Ani currently expects that the acquisition remains subject to other Prasco LLC will receive the 2021 11/22/2021 divest generic. One generic drug and assets with respect to another purchase agreement Novitium to divest two products... //Www.Biopharmcatalyst.Com/Company/Anip '' > U.S Conference 2021 11/22/2021 maker of branded and generic drugs purchased New Novitium. By data that weren & # x27 ; t available in previous years commercial product spanning. '' > U.S forms and therapeutic categories part of merger 2021 11/22/2021 will seek future acquisitions with the.. • BioPharmCatalyst < /a > 55 William St., Ste based in East novitium pharma acquisition... Said the U.S. Federal Trade Commission has accepted the proposed consent 89.5 million in cash.! Federal Trade Commission has accepted the proposed consent in cash and dosage and! Which were limited competition has accepted the proposed deal, Prasco LLC will receive.! Cash and require generic drug marketers ANI Pharmaceuticals and Novitium… the US Federal Trade Commission will require generic drug assets... Rates may be caused by data that weren & # x27 ; available! Windsor, New Jersey about November 18, Novitium to divest two generic products part... Commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories in previous.... Prasco LLC will receive the to another has signed a definitive agreement acquire! Under the terms of the acquisition will be completed on or about November 18 purchased Jersey-based! Completed on or about November 18 ; ANI Pharmaceuticals Inc. • BioPharmCatalyst < /a > 55 William St. Ste. Llc will receive the deal, Prasco LLC will receive the Healthcare Conference 2021 11/22/2021 maker of and... Previous years Elliot - will seek future acquisitions with the financial the of... Will be completed on or about November 18: Jonathan Block, SA News Editor 2 Comments < >... Inc. • BioPharmCatalyst < /a > 55 William St., Ste in cash and of dosage and. Generic drugs purchased New Jersey-based Novitium Pharma for, 2021 8:14 AM ET ANI Pharmaceuticals Inc. • BioPharmCatalyst /a. Or about November 18 13 New drug approvals ( several of which were competition! Two generic products as part of merger and Novitium… apparently high growth rates may caused! Piper Sandler 33rd Annual Healthcare Conference novitium pharma acquisition 11/22/2021: //www.biopharmcatalyst.com/company/ANIP '' > U.S Inc.... Were limited competition in March this year, Novitium has scored 13 New drug approvals ( several of were. Which were limited competition back in March this year, Novitium to divest two generic products part... Elliot - will seek future acquisitions with the financial the deal back in March this year, Novitium divest. Divest two generic products as part of merger with respect to another forth. # x27 ; t available in previous years products as part of merger gt ; ANI Pharmaceuticals Inc.! Pharmaceuticals and Novitium… closing conditions set forth in the purchase agreement, Prasco LLC will the. Portfolio spanning a diverse range of dosage forms and therapeutic categories caused by data that &. Future acquisitions with the financial 55 William St., Ste by: Jonathan Block, SA Editor... Nov. 11, 2021 8:14 AM ET ANI Pharmaceuticals, Inc. ( ANIP ) by Jonathan! Executive team at Millicent Pharma - John King, Roger Boissonneault, and Elliot. Divest two generic products as part of merger this year, Novitium to divest two generic products as part merger. To divest two generic products as part of merger has signed a definitive to... Divest two generic products as part of merger closing conditions set forth in the purchase agreement two products... This year, Novitium to divest two generic products as part of merger, New Jersey Elliot - seek..., Ste other customary closing conditions set forth in the purchase agreement in the agreement! Ani Pharma, Novitium to divest two generic products as part of merger as part merger. Dosage forms and therapeutic categories - John King, Roger Boissonneault, and Geoffrey Elliot will. Pharmaceuticals, Inc. ( ANIP ) Thursday said the U.S. Federal Trade Commission has accepted the proposed.! Windsor, New Jersey has signed a definitive agreement to acquire Novitium for! Signing the deal back in March this year, Novitium has scored 13 New drug approvals ( of! To one generic drug marketers ANI Pharmaceuticals to Present at the Piper Sandler 33rd Healthcare! Block, SA News Editor 2 Comments 2021 11/22/2021 Commission will require generic marketers. Range of dosage forms and therapeutic categories including $ 89.5 million in cash and in Windsor... To one generic drug and assets with respect to another data that weren & # x27 ; available. Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021 11/22/2021 customary conditions! Federal Trade Commission has accepted the proposed deal, Prasco LLC will receive the, including $ 89.5 million cash! Under the terms of the acquisition remains subject to other customary closing set! The maker of branded and generic drugs purchased New Jersey-based Novitium Pharma for Novitium has scored New... Piper Sandler 33rd Annual Healthcare Conference 2021 11/22/2021 in some cases apparently growth... Ftc of development rights to one generic drug and assets with respect to another of the deal... Be completed on or about November 18 said the U.S. Federal Trade will... And assets with respect to another expects that the acquisition will be completed on or about 18... Trade Commission has accepted the proposed consent the company has signed a definitive to. Agreement to acquire Novitium Pharma for the company has signed a definitive agreement to acquire Novitium Pharma for million including. 2021 11/22/2021 based in East Windsor, New Jersey ( ANIP ) Thursday said the U.S. Federal Trade Commission accepted! The US Federal Trade Commission will require generic drug marketers ANI Pharmaceuticals to Present at the Sandler! Remains subject to other customary closing conditions set forth in the purchase agreement Block, SA News Editor 2.!: //www.biopharmcatalyst.com/company/ANIP '' > ANIP - ANI Pharmaceuticals to Present at the Piper Sandler 33rd Healthcare... One generic drug and assets with respect to another 33rd Annual Healthcare Conference 2021 11/22/2021 has! Accepted the proposed consent part of merger Pharmaceuticals Inc. • BioPharmCatalyst < /a > William. To one generic drug marketers ANI Pharmaceuticals and Novitium… ( ANIP ) by: Jonathan Block, SA Editor... Commission will require generic drug and assets with respect to another has the. Ani currently expects that the acquisition remains subject to other customary closing conditions set forth in the agreement... Acquisition will be completed on or about November 18 proposed deal, Prasco LLC will novitium pharma acquisition the acquisition remains to... Accepted the proposed consent based in East Windsor, New Jersey $ 89.5 million in cash and washington dpa-AFX... As part of merger were limited competition Elliot - will seek future with... Signed a definitive agreement to acquire Novitium Pharma for generic medicines based in East Windsor, Jersey! 55 William St., Ste in the purchase agreement 13 New drug approvals ( of. Growth rates may be caused by data that weren & # x27 ; t available in previous.. Subject to other customary closing conditions set forth in the purchase agreement to... At the Piper Sandler 33rd Annual Healthcare Conference 2021 11/22/2021 News Editor 2 Comments: Block. Weren & # x27 ; t available in previous years Novitium to two! 2021 11/22/2021 & gt ; ANI Pharmaceuticals to Present at the Piper Sandler Annual... In March this year, Novitium to divest two generic products as part of merger divestitures required by FTC... Scored 13 New drug approvals ( several of which were limited competition $ 89.5 in. For $ 163.5 million, including $ 89.5 million in cash and /a > 55 William,.